Moreover, KIM-1 promotes the uptake of fatty acids by proximal tubular cells, promoting inflammation and fibrosis, contributing to the progression of DKD and potentially representing a therapeutic target [110]. The gene discussed is HAVCR1; the disease is diabetic kidney disease.